$NWBO 4 Gen 💰 Underscoring MAESTRO’s Strategy
Nov 11 London Conf Mega-deals are out, & more focused partnerships & licensing transactions are in What does it mean 4 capital return cycle? Pharma’s face growing divergence in regs & health policy btw key mkts
evanstony Re: Kam8 post# 793360 Monday, 10/20/2025 7:16:46 AM
I just hope BO immediately after MHRA Approval.
$18 per share please......
Immediately the terms may be disgusted and hopefully with more than one suitor. IMO we will hear about offer(s) within 3-4 months. IMO the low end estimate $14 and the high $25. I like the $18 number. Multiple suitors could easily push it over $20.
Approval IMO is this year and then .... LP is ready
Too many can not bear their own frustrationS nor that of REALITY for the last decade!
Why ILL equipt & not having the right mindset joggling this EPIC was a field day for DARK Forces for MOST capital intensive INDUSTRIES & COMPANIES!